Entecavir resistance is rare in nucleoside naïve patients with hepatitis B-Reference-Cited by-同舟云学术

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Published:2006 Issue:6 Volume:44 Page:1656-1665
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Colonno Richard J.,Rose Ronald,Baldick Carl J.,Levine Steven,Pokornowski Kevin,Yu Cheng F.,Walsh Ann,Fang Jie,Hsu Mayla,Mazzucco Charles,Eggers Betsy,Zhang Sharon,Plym Mary,Klesczewski Kenneth,Tenney Daniel J.

Publisher

Wiley

Subject

Hepatology

Reference30 articles.

1. Hepatitis B Virus Infection

2. Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium

3. Management of Patients with Decompensated HBV Cirrhosis

4. Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

5. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B;JGH Open;2023-07-21

2. Hepatitis B;The Lancet;2023-03

3. Antiviral Agents;Principles and Practice of Pediatric Infectious Diseases;2023

4. Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment;Journal of Clinical Virology;2022-06

5. Molecular Analysis of Hepatitis B Virus Reverse Transcriptase Domain for Mutations Associated with Viral Resistance in Pakistani Patients;Viral Hepatitis Journal;2021-12-23